US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

43.80

-0.6163-1.39%

Volume:216

Turnover:9.48K

Market Cap:5.48M

PE:- -

High:43.80

Open:43.80

Low:43.80

Close:44.42

52wk High:45.10

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.24

T/O Rate:0.17%

Dividend:0.62

Dividend Rate:1.42%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Sanofi, Regeneron Seem Keen to Keep Working Together

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Regeneron Posts Transcript of Q2 2026 Earnings Conference Call

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma

Regeneron announces Health Canada approval of new indication for Libtayo

Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

THOMSON REUTERS

Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop

Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens

Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million

Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million

Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference

Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1

Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook

Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment

Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":43.8,"timestamp":1787579259286,"preClose":44.4163,"halted":0,"volume":216,"delay":0,"changeRate":-0.01387553668360495,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Trading","change":-0.6163,"latestTime":"08-24 09:54:54 EDT","open":43.8,"high":43.8,"low":43.8,"amount":9479.115071999999,"amplitude":0,"askPrice":44.15,"askSize":300,"bidPrice":44.1,"bidSize":300,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":44.4163,"sharesOutstanding":100001,"nav":44.376,"aum":5547067.57,"dividendRate":0.014196,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":44.37,"preClose":44.4163,"latestTime":"16:10 EDT","volume":6,"amount":266.4978,"timestamp":1787343004463,"change":-0.0463,"changeRate":-0.001042,"amplitude":0},"volumeRatio":0.244645},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.244645,"shares":125000,"dividePrice":0.6218,"high":43.8,"amplitude":0,"preClose":44.4163,"low":43.8,"week52Low":25.71,"pbRate":"--","week52High":45.1,"institutionHeld":0,"latestPrice":43.8,"eps":0,"divideRate":0.014196,"volume":216,"delay":0,"ttmEps":0,"open":43.8,"prevYearClose":31.065,"prevWeekClose":44.4163,"prevMonthClose":34.3127,"prevQuarterClose":32.1223,"fiveDayClose":40.3209,"twentyDayClose":32.6646,"sixtyDayClose":29.6927},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657626282","title":"Moderna Inc. Stock Climbs 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626282?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:33","pubTimestamp":1786134780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 9.9% to $59.17 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.The stock's rise snapped a two-day losing streak.Moderna Inc. closed 30.9% short of its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $259.24, Pfizer Inc. rose 2.1% to $26.76, and Gilead Sciences Inc. rose 1.80% to $133.21.Trading volume totaled 6.8 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","LU1585245621.USD","BK4551","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0889565916.HKD","LU1061106388.HKD","GNOM","LU1066053197.SGD","LU1037948897.HKD","IE00B19Z3B42.SGD","IBB","MRNY","LU0114720955.EUR","WDNA","LU1430594728.SGD","BK4550","BK4501","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","TMED","LU2468319806.SGD","MEDI","LU0823416689.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1674673428.USD","LU1934455277.USD","GILD","LU2112291526.USD","BK4566","LGHT","LU0861579265.USD","MRNX","IE00BZ1G4Q59.USD","IDNA","LU1023059063.AUD","SG9999015978.USD","LU1066051498.USD","SG9999015952.SGD","MRNA","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657469640","title":"Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657469640","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657469640?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:36","pubTimestamp":1786120560,"startTime":"0","endTime":"0","summary":"Replimune Group received Food and Drug Administration clearance for its experimental skin cancer drug, concluding a saga that saw regulators twice deny its application. The stock was falling anyway.Th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU1983299246.USD","IOVA","BK4534","LU1023059063.AUD","LU0237698245.USD","LU1323610961.USD","BMY","IE0002141913.USD","LU1585245621.USD","IBBQ","LU1868837136.USD","REPL","LU2468319806.SGD","LU0306806265.USD","PJP","IE00BSNM7G36.USD","LU1868836591.USD","BK4585","LU2133065610.SGD","LABU","LU0225284248.USD","LU0061475181.USD","LU0289739699.SGD","SG9999001440.SGD","LU1093756168.USD","BK4533","AMGN","LU1670711123.USD","LU2242646821.SGD","PBE","LU1883839398.USD","BK4007","LU0225771236.USD","LU2089984988.USD","LU1718418525.SGD","LU0114720955.EUR","IHE","BK4532","TBXU","LU1061106388.HKD","BBH","IBB","LU0868494617.USD","LU1093756325.SGD","LU1989771016.USD","LU0321505868.SGD","BIB","LU0306807586.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657249641","title":"Sanofi, Regeneron Seem Keen to Keep Working Together","url":"https://stock-news.laohu8.com/highlight/detail?id=2657249641","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657249641?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:06","pubTimestamp":1786111560,"startTime":"0","endTime":"0","summary":"1406 GMT - Drugmakers Sanofi and Regeneron Pharmaceuticals seem to be exploring ways to work more strategically together again, Jefferies analysts say in a research note. They could work on extending the lifecycle of their blockbuster drug Dupixent or on next-generation immunology assets, even though neither company disclosed a new collaboration in recent earnings calls, the analysts say. The tone from executives at both Sanofi and Regeneron seemed to shift from their somewhat transactional relationship over the last few years, Jefferies says. Sanofi shares rise 2%, Regeneron's are little changed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","TBXU","LU0882574055.USD","IBBQ","LU0058720904.USD","LU2023250504.SGD","LU0889565916.HKD","LU0053666078.USD","LU0289739699.SGD","SNYNF","LU0823434583.USD","LU0823434740.USD","LU2106854487.HKD","BBH","BK4007","LU2362540622.SGD","REGN","LU2362541273.HKD","IBB","LU0109394709.USD","BK4585","LU0320765992.SGD","BK4139","LU2089984988.USD","LU1974910355.USD","LU0114720955.EUR","IE00BFXG1179.USD","SNY","LU2362541513.USD","LU1917777945.USD","LU2468319806.SGD","LU0823416689.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615971","title":"Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615971","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657615971?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:30","pubTimestamp":1786091400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 3.3% to 5.10 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 25668.03.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 44% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 88.6 million shares, compared to the 50-day average of 101.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","HK0000165453.HKD","LU0320765992.SGD","BK4534","LU1023059063.AUD","BK1589","IE00BZ08YR35.GBP","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","IE00BZ08YT58.USD","BK1521","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","LU0889565916.HKD","SG9999001440.SGD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK1515","PBE","BK1191","LU2089984988.USD","01177","TBXU","LU1061106388.HKD","BBH","IE00BZ08YS42.EUR","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369495","title":"Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369495?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:11","pubTimestamp":1786083103,"startTime":"0","endTime":"0","summary":"An update from Oxford BioMedica ( ($GB:OXB) ) is now available. Oxford Biomedica, a specialist cell and gene therapy CDMO, reported around 9% reven...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","BK4588","CNCR","GNOM","SYNB","JDOC","OXM","IDNA","IBBQ","LFSC","WDNA","BK4585","IBB","TBXU","BK4202","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682986","title":"Moderna Inc. Stock Sheds 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682986?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:35","pubTimestamp":1786048500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.3% to $53.86 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,348.35 and Dow Jones Industrial Average falling 0.9% to 53,885.10.This was the stock's second consecutive day of losses.Moderna Inc. closed 37.1% short of its 52-week high of $85.60, which the company reached on July 6th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.2% to $256.98, Pfizer Inc. rose 1.5% to $26.20, and Gilead Sciences Inc. fell 0.68% to $130.86.Trading volume totaled 5.5 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LGHT","LU0823416689.USD","BK4583","LU1571399168.USD","SG9999015978.USD","LU1430594728.SGD","IE00B3T34201.USD","LU2112291526.USD","MRNX","BK4548","BK4568","IE00B19Z3B42.SGD","BK4551","LU1674673691.USD","BIB","LU1066053197.SGD","IBBQ","LU1934455194.USD","BBH","LU2087621335.USD","MRNY","LU1934455863.HKD","LU1037948897.HKD","BK4566","GNOM","MRNA","LU1037948541.HKD","WDNA","LU0058720904.USD","LU1061106388.HKD","BK4532","SG9999015945.SGD","IE00B19Z3581.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","MEDI","LU0289739699.SGD","BK4578","TBXU","IDNA","BK4585","IBB","BMED","BK4139","BK4533","BK4501","LU0965509010.AUD","TMED","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665459","title":"Regeneron Posts Transcript of Q2 2026 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665459?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:48","pubTimestamp":1786042119,"startTime":"0","endTime":"0","summary":"Regeneron posts transcript of Q2 2026 earnings conference callRegeneron’s Q2 2026 earnings call drew CEO Leonard Schleifer, CSO George Yancopoulos, Commercial EVP Marion McCourt, CFO Christopher Fenimore.Revenue rose 17% to USD 4.3 billion; non-GAAP EPS increased 11% to USD 14.29, including a USD 0.99 hit from acquired IPR&D charges.EYLEA HD U.S. net sales reached USD 596 million, up 52%; management targeted EYLEA HD prefilled-syringe clearance before year-end using more than two CMOs.Sanofi collaboration revenue hit USD 2.2 billion; Fenimore flagged a step-up starting Q3 as the USD 3.1 billion Sanofi development balance was fully repaid.Management guided to August FDA action for garetosmab in FOP; November FDA decision for cemdisiran in gMG; PNH registrational readout in Q4.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL67NH1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0823434740.USD","LU0889565916.HKD","LU0823434583.USD","LU2362541513.USD","LU0109394709.USD","IBB","REGN","BK4139","LU0882574055.USD","LU0823416689.USD","LU1917777945.USD","LU0320765992.SGD","IBBQ","BK4585","BK4588","LU0289739699.SGD","LU2362540622.SGD","LU0114720955.EUR","LU2362541273.HKD","LU2468319806.SGD","LU1974910355.USD","LU0053666078.USD","LU0058720904.USD","BBH","LU2237438978.USD","TBXU","LU2106854487.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567836","title":"Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567836?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:59","pubTimestamp":1786035577,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) just unveiled an announcement. Vortex Energy Corp. reported final results from a technical study by Lonquist Fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2236285917.USD","LU2324357040.USD","LU2456880835.USD","LU1674673428.USD","LU2417539215.USD","BK4567","SG9999001176.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1585245621.USD","IBBQ","LU1778281490.HKD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU1430594728.SGD","BK4585","LU2462157665.USD","LU0061475181.USD","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1069344957.HKD","LU2362540622.SGD","LU0889565916.HKD","IDNA","LU1093756168.USD","LU2362541513.USD","VRTX","IE00BJJMRZ35.SGD","PBE","IE00B894F039.SGD","LU2089984988.USD","BK4532","LU0417517546.SGD","SGXZ57979304.SGD","TBXU","BBH","LU1035775433.USD","LU2237438978.USD","BK4139","SG9999013999.USD","IBB","IE00BJT1NW94.SGD","LU2362541273.HKD","IE00B19Z3B42.SGD","GNMX","LU0256863811.USD","LU0109394709.USD","SG9999001176.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657739653","title":"Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2657739653","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657739653?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:43","pubTimestamp":1786031036,"startTime":"0","endTime":"0","summary":"Aug 6 (Reuters) - Regeneron Canada::*REGENERON CANADA: LIBTAYO RECEIVES HEALTH CANADA APPROVAL FOR ADJUVANT TREATMENT OF HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 06-AUG-202615:30:00.257 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nRSD2CjPQd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","BK4585","BK4139","LU1917777945.USD","BBH","LU0058720904.USD","LU2468319806.SGD","BK4588","LU0320765992.SGD","LU2106854487.HKD","LU2237438978.USD","LU1974910355.USD","LU0823434740.USD","LU0823416689.USD","LU0823434583.USD","LU0882574055.USD","LU0889565916.HKD","TBXU","LU2362541513.USD","LU0289739699.SGD","LU0109394709.USD","LU0114720955.EUR","LU0053666078.USD","LU2089984988.USD","IBB","IBBQ","LU2362541273.HKD","LU2023250504.SGD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657653754","title":"Regeneron announces Health Canada approval of new indication for Libtayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657653754","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657653754?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:35","pubTimestamp":1786030528,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Canada announced that Health Canada has issued a Notice of Compliance for Libtayo for the adjuvant treatment of adult patients wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-announces-health-canada-approval-of-new-indication-for-libtayo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-announces-health-canada-approval-of-new-indication-for-libtayo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2106854487.HKD","TBXU","LU0889565916.HKD","BBH","LU2237438978.USD","IBBQ","LU0320765992.SGD","LU2023250504.SGD","LU1917777945.USD","LU0882574055.USD","IBB","LU0823416689.USD","BK4585","LU0114720955.EUR","BK4139","REGN","LU2089984988.USD","LU2362540622.SGD","LU0289739699.SGD","LU0053666078.USD","LU0058720904.USD","LU2362541273.HKD","LU2468319806.SGD","BK4588","LU0109394709.USD","LU2362541513.USD","LU0823434740.USD","LU1974910355.USD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657653183","title":"Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2657653183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657653183?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:30","pubTimestamp":1786030236,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4431G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2362541273.HKD","LU2468319806.SGD","LU0320765992.SGD","LU2362540622.SGD","LU0289739699.SGD","IBBQ","TBXU","LU1974910355.USD","LU2237438978.USD","LU0109394709.USD","LU0889565916.HKD","BK4585","LU2089984988.USD","LU0823434583.USD","LU0823434740.USD","REGN","BK4139","LU2023250504.SGD","LU1917777945.USD","LU0053666078.USD","BBH","BK4588","IBB","LU0058720904.USD","LU0823416689.USD","LU0882574055.USD","LU2106854487.HKD","LU2362541513.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657585496","title":"Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2657585496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657585496?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:46","pubTimestamp":1786027560,"startTime":"0","endTime":"0","summary":"DJ Salesforce, UnitedHealth Share Losses Contribute To Dow's Nearly 150-Point DropThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Salesforce and UnitedHealth are seeing declines Thursday morning, dragging the Dow Jones Industrial Average into negative territory.Shares of Salesforce  and UnitedHealth  have contributed to the blue-chip gauge's intraday decline, as the Dow  was most recently trading 144 points lower .Salesforce's shares have fallen $6.53  while those of UnitedHealth have declined $6.27, or 1.5%, combining for a roughly 76-point drag on the Dow.Also contributing significantly to the decline are Boeing , Honeywell , and Amgen .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","SG9999014898.SGD","LU0889565833.HKD","LU1988902786.USD","LU0211327993.USD","LU1674673691.USD","LU0109392836.USD","BK4154","IE0004445015.USD","LU0557290698.USD","TMED","LU1066051498.USD","BK4607","LU2247934214.USD","IE00BZ1G4Q59.USD","LU0342679015.USD","LU0868494708.USD","SG9999001176.SGD","LU0310800379.SGD","LU0162691827.USD","LU1791710400.SGD","IXJ","LU0795875169.SGD","BIB","BK4602","MISL","LU0109394709.USD","LU0648000940.SGD","LU2999663052.SGD","SG9999014880.SGD","BK4579","BOED","LU2125154778.USD","LU1261432733.SGD","JDOC","PJP","IE00BJT1NW94.SGD","LU0689626769.HKD","LU1720051108.HKD","LU0097036916.USD","BK4581","LU2324357040.USD","LU1069347547.HKD","BK4206","HON","IE00BFXG1179.USD","LU0058720904.USD","LU0079474960.USD","LU0211328371.USD","BOEU","LU0289739343.SGD","IHF","LU0072461881.USD","LU2211815571.USD","LU1914381329.SGD","LU0238689110.USD","UNHU","LU1064131342.USD","LU1267930490.SGD","04332","BK4543","IE00B19Z3B42.SGD","BK4551","IE00BJTD4N35.SGD","LU1119994496.HKD","LU0965509283.SGD","LU1023059063.AUD","IE00BKPKM429.USD","LU2028103732.USD","LU0158827781.USD","IE00B19Z8X17.USD","LU2360032135.SGD","LU0683600562.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2326559502.SGD","SGXZ81514606.USD","LU0149725797.USD","LU2491049909.HKD","SGXZ31699556.SGD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU2089284900.SGD","LU0077335932.USD","LU1057294990.SGD","AMGN","LU2362540622.SGD","LU1074936037.SGD","TRUH","LU0053666078.USD","LU0820562030.AUD","LU0234570918.USD","LU0354030438.USD","LU0943347566.SGD","LU1791710582.SGD","LU0354030511.USD","LU0477156953.USD","SG9999014906.USD","LU1854104046.USD","BK4613","LU0011850046.USD","LU1989764748.USD","IE00BQXX3D17.EUR","LU0528227936.USD","BK4532","LU0048573561.USD","LU1035773651.USD","IE00BFTCPJ56.SGD","LU2552382132.HKD","LU1670627923.USD","LU0128525689.USD","LU0082616367.USD","SG9999001176.USD","LU1267930227.SGD","LU0496365809.HKD","LU0107464264.USD","LU0310800965.SGD","LU0316494557.USD","IE00B2B36J28.USD","LU1951198990.SGD","LU1670628061.USD","LU2242646821.SGD","LU1548497426.USD","LU2244417387.USD","IE00B19Z8W00.USD","RXL","IE000M9KFDE8.USD","IE00BWXC8680.SGD","LU1084165304.USD","BK4585","LU1571399168.USD","IE0005OL40V9.USD","LU1814569148.SGD","LU0266013472.USD","IE00B1BXHZ80.USD","LU1989764664.SGD","LU0949170772.SGD","BK4598","LU0820561909.HKD","LU0708995401.HKD","VHT","LU0251131958.USD","IE00BJJMRY28.SGD","LU2264538146.SGD","LU1496350502.SGD","LU1366333091.USD","ITA","LU2461242641.AUD","SG9999002232.USD","IBBQ","LU2458330169.SGD","LU2361044865.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0719512351.SGD","IDEF","LU0432979614.USD","BK4505","IE00B775H168.HKD","LU1435385759.SGD","LU2286300806.USD","LU0353189763.USD","LU1778281490.HKD","LU0130518102.USD","CRMG","LU2362541513.USD","LU1989771016.USD","LU0081259029.USD","LU0553294199.USD","IE00BKVL7J92.USD","LU2265009873.SGD","LU1003077747.HKD","IE00B19Z9P08.USD","LU0320765059.SGD","LU0672654240.SGD","LU0158827948.USD","IBB","SG9999017495.SGD","BA","LU0006306889.USD","LU0942090050.USD","MHIP","BK4548","BK4187","LU0234572021.USD","LU0114720955.EUR","LU0472753341.HKD","SGXZ99366536.SGD","LU0648001328.SGD","LU0417517546.SGD","LU1854103824.USD","BK4527","BBH","LU0738911758.USD","BK4023","IE00B1XK9C88.USD","LU1046421795.USD","IE00BN29S564.USD","PPA","IE0034235188.USD","LU1267930730.SGD","LU0353189680.USD","LU2357305700.SGD","LU1291159041.SGD","LU1201861249.SGD","SG9999001440.SGD","LU0052756011.USD","LU1732800096.USD","LU1316542783.SGD","BK4533","LU0198837287.USD","LU1674673428.USD","LU1718418525.SGD","IE00B4JS1V06.HKD","LU2242649171.HKD","LU0251132253.USD","LU2089984988.USD","IYH","LU0820561818.USD","LU2491050154.USD","IE00BQXX3C00.GBP","LU1323610961.USD","SG9999018857.SGD","LU2552382215.SGD","IE00B894F039.SGD","UNHG","LU0251142724.SGD","LU0289961442.SGD","LU0792757196.USD","LU2954938101.SGD","LU1923623000.USD","LU0310799852.SGD","LU0187121727.USD","SG9999002224.SGD","LU0256863811.USD","LU0477156797.USD","LU0795875086.SGD","IE00B19Z3581.USD","LU0314104364.USD","LU0661504455.SGD","LU0057025933.USD","LU2462591277.SGD","LU0211326755.USD","LU2133065610.SGD","LU0787776722.HKD","LU0965509101.SGD","IE00BFSS7M15.SGD","LU1037948897.HKD","LU0511384066.AUD","CRM","LU1066051811.HKD","SGXZ51526630.SGD","LU0320765992.SGD","LU2087625088.SGD","LU1267930573.SGD","IE0002141913.USD","LU2112291526.USD","LU0545039389.USD","LU0823416689.USD","IE00BQXX3F31.USD","SG9999018865.SGD","LU1823568750.SGD","LU2458330243.SGD","BK4535","BK4608","LU0127658192.USD","LU2756315318.SGD","LU1066051225.USD","LU1551013425.SGD","LU0642271901.SGD","LU2279689827.SGD","FHLC","LU0980610538.SGD","LU1934455863.HKD","NATO","BK4516","LU1235294995.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","LU1551013342.USD","BK4538","LU2236285917.USD","IE00BJJMRX11.SGD","LU1153585028.USD","LU0109391861.USD","UNH","BK4567","FOWF","SG9999014914.USD","LU1934455277.USD","LU0124676726.USD","LU0456855351.SGD","LU0912757837.SGD","LU0742534661.SGD","SG9999013999.USD","TBXU","LU0106261372.USD","LU2242652126.USD","LU1506573853.SGD","PBE","LU0029864427.USD","LU2362541273.HKD","IE00B7KXQ091.USD","LU0143551892.USD","LU1201861165.SGD","LU2125154935.USD","LU1804176565.USD","IE00B19Z9505.USD","GDOC","LU0130517989.USD","LU0128525929.USD","LU0211326839.USD","LU2347655156.SGD","LU0048584097.USD","LU0267386448.USD","LU2023251221.USD","LU1061106388.HKD","IE00B19Z9Z06.USD","LU0094547139.USD","LU1496350171.SGD","BK4528","UNHW","LU0289739699.SGD","LU1720051017.SGD","LU2271345857.HKD","BOEG","LU0708994859.HKD","LU0122379950.USD","BK4564","HRTS","LU1803068979.SGD","LU0861579265.USD","LU0689472784.USD","LU0965509010.AUD","LU0203345920.USD","LU1732799900.SGD","IE0004445239.USD","LU2468319806.SGD","LU1951200564.SGD","LU1429558221.USD","BK4534","LU0345770308.USD","LU1037948541.HKD","LU0965508806.USD","IE00BZ9MQY76.HKD","IE00BJTD4V19.USD","LU0889566641.SGD","LU0345770993.USD","LU2361044949.HKD","LU2361045086.USD","LU0157215616.USD","LU2552382058.USD","LU0889565916.HKD","LU0976567544.SGD","LU1934455194.USD","LU2491050071.SGD","LU0868494617.USD","IE0009355771.USD","LU0069063385.USD","BK4139","BK4588","IE0002270589.USD","LU1267930813.SGD","LU0130102774.USD","LU1983299246.USD","BK4550","BK4566","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","XLV","LU0882574055.USD","BK4561","IE00BSNM7G36.USD","LU0130103400.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560633","title":"Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560633","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:20","pubTimestamp":1786015252,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics Q2 collaboration revenue falls, net loss widensOverviewU.S. gene editing firm's Q2 collaboration revenue fell yr/yr due to lower Regeneron revenueQ2 net loss widened from prior y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2362540622.SGD","LU2106854487.HKD","LU1861559042.SGD","LU1861558580.USD","BK4535","BK4585","LU2362541513.USD","LU1974910355.USD","LU0823434583.USD","IBB","ARKG","LU2089984988.USD","LU0823434740.USD","LU2237438978.USD","NTLA","BBH","IBBQ","LU0289739699.SGD","REGN","LU0882574055.USD","CRSP","LU0053666078.USD","LU2362541273.HKD","BK4611","TBXU","LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0823416689.USD","LU2023250504.SGD","BK4588","PGEN","BK4139","BK4556","EDIT","LU0058720904.USD","LU1917777945.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638109","title":"Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638109","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638109?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:09","pubTimestamp":1786014575,"startTime":"0","endTime":"0","summary":"Intellia Q2 FY26 net loss widens to $106.63 million; revenue falls to $7.66 millionIntellia posted a GAAP net loss of USD 106.63 million, widening from USD 101.26 million a year earlier; loss per shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3QMBnk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU2106854487.HKD","BBH","LU1917777945.USD","LU0889565916.HKD","LU1861558580.USD","LU2362540622.SGD","LU2089984988.USD","LU1861559042.SGD","IBBQ","LU2362541273.HKD","LU2237438978.USD","LU0823416689.USD","LU0320765992.SGD","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","LU2362541513.USD","LU2468319806.SGD","BK4556","BK4139","NTLA","LU0823434583.USD","LU1974910355.USD","IBB","BK4535","BK4585","LU0109394709.USD","BK4588","LU2023250504.SGD","REGN","LU0053666078.USD","LU0882574055.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682336","title":"Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682336","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682336?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:11","pubTimestamp":1786011111,"startTime":"0","endTime":"0","summary":"Generate Biomedicines Q2 FY26 net loss widens to $67.26 million; revenue drops to $6.31 millionGenerate Biomedicines posted a GAAP net loss of $67.26 million for the quarter ended June 30, 2026, widen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL8LfD7q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1571399168.USD","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","BK4599","BBH","LU0868494617.USD","LU0058720904.USD","GENB","LU2468319806.SGD","IE0002141913.USD","BK4588","LU0320765992.SGD","LU0122379950.USD","AMGN","LU1023059063.AUD","LU2112291526.USD","PBE","LU0889565916.HKD","TBXU","LU1983299246.USD","LU0289739699.SGD","PJP","LU0109394709.USD","LU1057294990.SGD","BK4533","IE00B2B36J28.USD","LU2089984988.USD","BK4581","IBB","IBBQ","LU2242652126.USD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657023575","title":"Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2657023575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657023575?lang=en_us&edition=fundamental","pubTime":"2026-08-06 13:45","pubTimestamp":1785995139,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA, a biotechnology company specializing in circular RNA expression systems...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","RDMX","FWD","BBP","BK4588","IBB","TBXU","JDOC","CNCR","LFSC","XT","IBBQ","SYNB","EPV","RSPH","IEIH","LNGR","RNA","AGNG","FHLC","BK4505","IE0009354923.USD","BK4139","FBT","GNOM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572786","title":"Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:25","pubTimestamp":1785972320,"startTime":"0","endTime":"0","summary":"The latest update is out from Takeda Pharmaceutical Co ( ($JP:4502) ). Takeda has secured U.S. FDA approval for ORZEYFUL, an oral orexin receptor 2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","TBXU","MRNY","LABU","GDOC","PSCH","RSPH","IDNA","TECB","IBB","BK4585","SYNB","BBP","GNMX","IYH","MRNX","PINK","LFSC","FRTY","BK4588","BMED","NVIB","XLVX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657357543","title":"Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657357543","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657357543?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:53","pubTimestamp":1785963209,"startTime":"0","endTime":"0","summary":"Exelixis Q2 revenue misses analyst estimates, lowers 2026 outlookOverviewU.S. oncology firm's Q2 revenue rose yr/yr but missed analyst expectationsAdjusted net income for Q2 beat analyst estimatesComp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","BIB","LU2242652126.USD","BK4588","BK4532","PJP","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","URGN","LU1057294990.SGD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","TBXU","BK4533","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578623","title":"Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578623","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578623?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:20","pubTimestamp":1785961240,"startTime":"0","endTime":"0","summary":"Vir Biotechnology Q2 revenue up, beats estimates on Astellas paymentOverviewU.S. biopharma's Q2 revenue rose sharply, beating analyst expectationsQ2 net income was $80.1 mln, reversing a net loss last","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU2324357040.USD","LU1674673691.USD","LU0058720904.USD","SG9999015945.SGD","KYMR","IE00B4R5TH58.HKD","LU1585245621.USD","IBBQ","LU0861579265.USD","LU2087621335.USD","LU0882574055.USD","BK4599","BK4535","PJP","MEDI","IE00BSNM7G36.USD","LU1430594728.SGD","BK4550","VIR","LU1934455863.HKD","LU0289739699.SGD","LU1057294990.SGD","LU1066051498.USD","LU0889565916.HKD","LU0823416689.USD","SG9999015978.USD","AMGN","IE00BJJMRZ35.SGD","BMED","PBE","BK4568","LU0114720955.EUR","BK4532","TBXU","LU1061106388.HKD","BBH","IE00BJT1NW94.SGD","IBB","GILD","IE00B19Z3B42.SGD","LU0868494617.USD","LU0965509101.SGD","TMED","LU0234570918.USD","LU1839511570.USD","BIB","IE00B3T34201.USD","LU1571399168.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657224905","title":"Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000","url":"https://stock-news.laohu8.com/highlight/detail?id=2657224905","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657224905?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:36","pubTimestamp":1785958615,"startTime":"0","endTime":"0","summary":"Gilead Sciences declares Q3 2026 distribution of R$ 1.42 per unit for BRGILDBDR 000Gilead declared a 3Q 2026 cash distribution of R$ 1.42 per unit for ISIN BRGILDBDR000.Shares trade with entitlement t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL34j8pX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","GILD","BIB","LU0109394709.USD","IE00BSNM7G36.USD","LU1037948541.HKD","BK4583","LU1674673428.USD","LU1934455863.HKD","IE00B19Z3B42.SGD","IBBQ","MEDI","SG9999015978.USD","LU0320765992.SGD","LU2112291526.USD","IE0002270589.USD","LU0882574055.USD","LU0965509101.SGD","LU1057294990.SGD","LU0889565916.HKD","BK4566","IE00B3T34201.USD","SG9999015952.SGD","LU0289739699.SGD","LU2324357040.USD","LU0234570918.USD","LU1934455194.USD","LU2089984988.USD","LU1674673691.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4568","BK4532","LU1037948897.HKD","LU1585245621.USD","BBH","LU2468319806.SGD","LU0965509283.SGD","IBB","LU0122379950.USD","BMED","TMED","TBXU","LU1778281490.HKD","LU1061106388.HKD","LU0114720955.EUR","LU1839511570.USD","SG9999015986.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}